Picture of Clinical Laserthermia Systems AB logo

CLS B Clinical Laserthermia Systems AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: CLS Expects To Achieve Positive Cash Flow From Q4 2026 To Q1 2028

April 28 (Reuters) - Clinical Laserthermia Systems AB CLSRb.ST:

CLS STRENGTHENS ITS STRATEGIC PARTNERSHIP IN NEUROSURGERY AND AIMS TO BECOME MARKET LEADER IN NEURO LITT

CLINICAL LASERTHERMIA SYSTEMS AB - UPDATING GUIDANCE FOR ACHIEVING POSITIVE CASH FLOW FROM Q4 2026 TO Q1 2028

Source text: ID:nWkr922tdq

Further company coverage: [CLSRb.ST]

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Clinical Laserthermia Systems AB

See all news